Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in colorectal liver metastases;Arginaza jako marker procesu nowotworowego. III. Porównanie aktywności arginazy z CEA i Ca 19-9 w przerzutach raka jelita grubego do wa̧troby

Polski Merkuriusz Lekarski

Volumn 16, Issue 91, 2004, Pages 31-33

  Porembska, Zofia ^a   Skwarek, Anna ^a   Chrzanowska, Alicja ^a   Mielczarek, Magdalena ^a   Nyckowski, Paweł ^a   Baranczyk Kuźma, Anna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Arginase; Ca 19 9; CEA; Colorectal liver metastases; Neoplastic markers

Indexed keywords

ARGINASE; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CARCINOGENESIS; COLORECTAL LIVER METASTASIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYMOLOGY; IMMUNOLOGY; LIVER TUMOR; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ARGINASE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 2442684355     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chinard F.P.: Photometric estimation of proline and ornithine. J. Biol. Chem., 1952, 199, 91-95.
2. Grotowski M., Maruszyński M., Piechota W.: Przydatnoś ć przedoperacyjnego oznaczania antygenów CEA i CA19-9 u chorych na raka jelita grubego. Pol. Merk. Lek., 2001, 66, 476-479.
3. Haglund C.: Tumor marker antigen CA 125 in pancreatic cancer: A comparison with CA 19-9 and CEA. Br. J. Cancer., 1986, 54, 897-901.
4. Koprowski H., Steplowski K.: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet., 1979, 5, 957-972.
5. Magnani J.L. i wsp.: A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem., 1982, 257, 14365-14369.
6. Moertel C.G. i wsp.: An evolution of the carcinoembrionic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA, 1993, 270, 943-947.
7. Porembska Z. i wsp.: Arginase isoforms in human colorectal cancer. Clin. Chim. Acta, 2001, 305, 157-165.
8. Porembska Z. i wsp.: Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma. Cancer, 2002, 94, 2930-34.